their Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S. webmaster Tuesday, December 17, 2024
Unit Granules India’s Unit V Facility SecuresUS FDA EIR with 'No Action Indicated' Status webmaster Saturday, November 09, 2024
Such Q2 Revenue up 9% YoY to ₹5,179 crore and PAT up 32% YoY to ₹94 croreH1 Revenue up 9% YoY to ₹10,182 crore and PAT up 72% YoY to ₹205 crore webmaster Tuesday, October 29, 2024